UCSF researchers are recommending six comprehensive measures to prevent the spread of hepatitis C for the estimated 31,000 young people who may be newly infected each year in the U.S. due to injection-drug use.
July 11, 2012
The UCSF-affiliated Ernest Gallo Clinic and Research Center has been selected to administer and manage a U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.
June 01, 2012
New UCSF research builds on a 1978 study called the “holiday heart syndrome,” establishing a stronger causal link between alcohol consumption and serious palpitations in patients with atrial fibrillation, the most common form of arrhythmia.
May 03, 2012
A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal published a study in July 2011 reporting “risk of serious adverse cardiovascular events associated with varenicline.” UCSF researchers, however, question the way the previous study was conducted, and their new analysis, scheduled to be published May 4 in BMJ, reaches a very different conclusion.
May 02, 2012
The smoking cessation drug varenicline significantly reduced alcohol consumption in a group of heavy-drinking smokers, in a study carried out by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.
April 18, 2012
Half of young adult tobacco smokers also have smoked marijuana in the last 30 days, according to a recent Facebook-based survey conducted by UCSF researchers, indicating a greater prevalence of marijuana and tobacco co-use among smokers age 18-25 than previously reported.
March 15, 2012
A group of scientists at UCSF has discovered that a tiny molecule in the fly’s brain govern the behavior of males who go on a drinking binge after female fruit flies reject their sexual advances.
January 11, 2012
Drinking alcohol leads to the release of endorphins in areas of the brain that produce feelings of pleasure and reward, according to a study led by researchers at the Ernest Gallo Clinic and Research Center at UCSF.
November 01, 2010
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
September 01, 2010
Ezlopitant, a compound known to suppress craving for alcohol in humans, was shown to decrease consumption of sweetened water by rodents in a study by researchers at the Ernest Gallo Clinic and Research Center, which is affiliated with UCSF.